BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Policy

  ADMS LOSS NOTICE ALERT: TOP RANKED Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Adamas Pharmaceuticals, Inc. - ADMS

  Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Adamas Pharmaceuticals, Inc. between August 8, 2017 and September 30, 2019, inclusive.

  December 14, 2019

   · 

  2 min read
• Job Trends

  Myriad’s Polygenic Risk Score Personalizes Risk of Breast Cancer for Woman with a Genetic Mutation in Important Breast Cancer GenesNew Clinical Validation Study Presented at 2019 San Antonio Breast Cancer Symposium

  Myriad Genetics, Inc., a leader in molecular diagnostics and precision medicine, announced that results of a new validation study of the company’s polygenic risk score for breast cancer were presented at the 2019 San Antonio Breast Cancer Symposium in San Antonio, Tx.

  December 14, 2019

   · 

  10 min read